Noticias de QNCX_US

Noticias del mercado

Últimas noticias sobre QNCX_US — 104 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: QNCX_US ✕ 104 resultados
22/04/2026 QNCX_US — MarketScreener
Quince Therapeutics, Inc. Appoints June Bray as Class I Director and to Nominating & Governance Committee, Audit Committee, and Compensation Committee, Effective April 22, 2026
22/04/2026 QNCX_US — Stock Titan
[8-K] Quince Therapeutics, Inc. Reports Material Event | QNCX 8-K Filing
22/04/2026 QNCX_US — TipRanks
Quince Therapeutics Appoints June Bray to Board
22/04/2026 QNCX_US — Investing.com UK
Quince Therapeutics appoints June Bray to board of directors By Investing.com
22/04/2026 QNCX_US — Investing.com
Quince Therapeutics appoints June Bray to board of directors
21/04/2026 QNCX_US — ChartMill ES ← EN
Precio, cotización y gráfico de acciones de QNCX | QUINCE TERAPÉUTICA INC (NASDAQ:QNCX)

QNCX Stock Price, Quote & Chart | QUINCE THERAPEUTICS INC (NASDAQ:QNCX)

20/04/2026 QNCX_US — sonla.gov.vn
Quince Therapeutics (QNCX) Stock: Worth Entering? (-6.93%) 2026-04-20 - Top Breakouts
20/04/2026 QNCX_US — vinhcong.tayninh.gov.vn
Quince Therapeutics (QNCX) Stock: Worth Entering? (-6.93%) 2026-04-20 - Top Breakouts
18/04/2026 QNCX_US — GuruFocus
QNCX Sees Increased Price Target Amidst Maintained Buy Rating |
18/04/2026 QNCX_US — ADVFN
Form S-8 - Securities to be offered to employees in employee benefit plans
18/04/2026 QNCX_US — ADVFN
Form PRE 14A - Other preliminary proxy statements
16/04/2026 QNCX_US — intelligentinvestor.com.au
Quince Therapeutics Inc. (NASDAQ: QNCX) - Share Price
11/04/2026 QNCX_US — MarketScreener
Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
10/04/2026 QNCX_US — Stock Titan
Phase 3 miss leaves Quince Therapeutics (QNCX) chasing reverse merger path
10/04/2026 QNCX_US — MSN
MSN Money
10/04/2026 QNCX_US — TradingView
Quince Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
10/04/2026 QNCX_US — TradingView
QNCX: Lead asset failed in Phase 3, triggering strategic review and raising going concern risks
10/04/2026 QNCX_US — MSN
MSN Money
10/04/2026 QNCX_US — The Globe and Mail
Quince Therapeutics Announces 1-for-10 Reverse Stock Split
09/04/2026 QNCX_US — Sahm
Dow Jumps Over 1,300 Points; Delta Air Lines Shares Gain After Q1 Results

Página 3 de 6

keyboard_arrow_up